/Companies

AI & Machine Learning Startups

32,267 companies tagged AI & Machine Learning, with their investors and founders.

Bioceanor

BiOceanOr offers AI-powered water quality monitoring and forecasting tools for aquaculture operators, combining biology and machine learning to predict oxygen levels, prevent hypoxia, and optimize feeding and aeration. Its products, such as the PREDIMAR oxygen prediction system, use real-time sensor, satellite, and sampling data to help fish farmers protect animal welfare and improve performance.

1 investor

Biocentis

Biocentis uses genome engineering, artificial intelligence, and a proprietary technological platform to develop insect control solutions that suppress harmful insect reproduction while reducing reliance on chemical insecticides. Its technology targets disease-carrying insect vectors and crop pests to support public health, agriculture, and biodiversity.

1 investor

Biodesignlab

Bio Design Lab uses synthetic biology to engineer viral vector components, offering retroviral and lentiviral vectors designed to shift transgene integration away from proto-oncogenes for improved safety and enhanced transduction efficiency. Its vectors support gene therapies, cell therapies (including T and NK cells), vaccine platforms, and protein-producing cell lines.

1 investor

Biodiversity Intelligence

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

Bioelectronica

Bioelectronica develops hardware and software tools for accelerated antibody discovery using single-cell protein secretion sorting combined with AI-driven sequence analysis. The company serves research institutions and biotech firms in the life sciences industry.

1 investor

Biofourmis

Biofourmis develops digital health technology aimed at improving patient care and clinical outcomes. The company applies data and science to make care delivery simpler for patients and healthcare providers.

1 investor

Biolattice

BioLoom is a configurable robotic bioprinting platform for multi-material biofabrication, combining MEW, DIW, MEX, and FDM in a single build with dual independent IDEX turrets, a sealed GMP-ready chamber, and computer-vision monitoring. It serves biotech and tissue-engineering researchers for fabricating human-relevant tissue constructs, organoids, and scaffolds for drug screening and regulated manufacturing.

1 investor

Biolinco

Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.

1 investor

BioLM

BioLM provides AI/ML solutions for protein and DNA analysis, serving researchers and scientists in the biotechnology and synthetic biology sectors with tailored models and APIs.

1 investor

Biome Makers

Biome Makers is an AgTech company that uses DNA sequencing and its BeCrop technology to analyze soil microbiome data and deliver soil health intelligence for yield limitations, disease diagnosis, and input product evaluation. It serves farmers, agronomic advisors and retailers, ag input manufacturers, and food and beverage companies worldwide.

1 investor

Biomech Holdings

BioMech develops wireless, noninvasive motion sensors and analytics software (BioMech Lab and BioMech AI) that capture and stream three-dimensional motion in real time. Its platform serves healthcare, sports/wellness, and industrial markets to quantify and improve movement outcomes.

1 investor

BiomEdit

BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.

1 investor

Biomod AI

BioModAI provides an autonomous AI agent that designs molecular biology assays, primers, CRISPR guides, and DNA constructs for research and biotech teams. The agent runs real bioinformatics tools on actual genomic data and delivers publication-ready reports with full audit trails, typically within hours.

1 investor

Bionamic

Bionamic provides a spreadsheet-based platform for annotating and profiling antibody and molecule developability, turning raw sequences into workbook records with features like numbering, PTM motifs, CDR ranges, and developability predictions (immunogenicity, solubility, aggregation propensity). It serves biotech and drug discovery teams working on molecule profiling and decision-making.

1 investor

Bionl

Pan.bio provides automated, reproducible genomic analysis workflows that process raw sequencing data into structured clinical-grade outputs, supporting both research and clinical applications. The platform integrates nf-core pipelines, Nextflow workflows, and AI-assisted guidance to standardize analysis across teams.

1 investor

Bionline

BIonline offers an artificial intelligence platform for sales and marketing optimization, with prediction models for cross-selling, personalized recommendations, upselling, churn prevention, and next best action. Its web application is designed for business users and integrates with existing CRM and marketing automation systems.

1 investor

Bionomous

Bionomous builds automated precision sorting systems for small round biological entities (roughly 500 μm to 2 mm), such as fish embryos, 3D cell models, aquaculture samples, and plant seeds. Its products serve research labs and industrial operations seeking to automate repetitive manual sorting and standardize quality control.

1 investor

Biophy

BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.

1 investor

Bios

Waddle Labs is an applied AI research lab developing large language models that control robots, with a focus on letting individuals adapt robots to their own tasks and environments. Its research spans continual learning for transferring agent knowledge, real-time inference efficiency on physical robots, and human-robot interaction interfaces.

1 investor

Bioscan Research

BioScan Research develops a portable, non-invasive device that uses light, electronics, mechanics, and machine learning to detect intracranial hemorrhage at the point of care for trauma patients. The technology is aimed at paramedics and minimally trained clinical staff to speed up triage of head injuries without the infrastructure of a CT scanner.

1 investor

BIOSEEK Semantic search engine

BioSeek builds an AI platform for drug discovery that unifies fragmented biological sources—literature, patents, clinical, and chemistry data—into a connected knowledge graph, with specialist agents that reason across it from disease biology to safety-screened molecules. The software is deployed inside a customer's own infrastructure so proprietary data and tools join the private graph without leaving their environment, targeting enterprise pharma and biotech research teams.

1 investor

Biosortia Pharmaceuticals

Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.

1 investor

Biospectal

Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.

1 investor

Biosymetrics

BioSymetrics builds an AI/ML and in vivo validation platform that combines clinical records, genomic profiles, and experimental data to identify disease subtypes, biomarkers, and higher-confidence drug targets for precision medicines. It applies this workflow to areas including precision neurology, neuropsychiatry, rare neurological disorders, and biodefence, serving drug discovery and clinical trial optimization.

1 investor

Other sectors & tags